Assessment of tumor oxygenation by electron paramagnetic resonance: Principles and applications

NMR in Biomedicine

Volumn 17, Issue 5, 2004, Pages 240-262

  Gallez, Bernard ^a,b   Baudelet, Christine ^a   Jordan, Bénédicte F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CMFA/REMA   (Belgium)

Author keywords

Cancer; Dynamic nuclear polarization; EPR; ESR; Imaging; In vivo; Irradiation; Nitric oxide; NMR; OMRI; Oxygen; PEDRI; Spectroscopy; Tumor

Indexed keywords

MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE; OXYGEN SENSORS; PARAMAGNETIC RESONANCE; SPECTROSCOPY; TOXIC MATERIALS; TUMORS;

MICROENVIRONMENT; OXYGEN TENSION; OXYGENATION; PHARMACOLOGICAL INTERVENTION;

ONCOLOGY;

ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARBON; COAL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORINE; INK; NORADRENALIN; PHTHALOCYANINE DERIVATIVE; POTASSIUM CHANNEL STIMULATING AGENT; VASODILATOR AGENT; VASOPRESSIN;

ANGIOGENESIS; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CYTOTOXICITY; DISEASE COURSE; DRUG MECHANISM; ELECTRON SPIN RESONANCE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HYPOXEMIA; IN VIVO STUDY; INTERMETHOD COMPARISON; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MICROENVIRONMENT; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; OXYGEN BLOOD LEVEL; OXYGEN TENSION; PHENOTYPE; PHOTODYNAMIC THERAPY; POLARIZATION; POLAROGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; REVIEW; TISSUE OXYGENATION;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL RESPIRATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; OXIMETRY; OXYGEN; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TUMOR MARKERS, BIOLOGICAL;

EID: 4644283094     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.900     Document Type: Review

References (249)

1. Vaupel P, Kelleher DK, Thews OT. Modulation of tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 1998; 42: 843-848.
2. Less JR, Shalak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimension. Cancer Res. 1991; 51: 265-273.
3. Munn LL. Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov. Today 2003; 8: 396-403.
4. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 2000; 156: 1363-1380.
5. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002; 62: 5381-5385.
6. Boucher Y, Leunig M, Jain RK. Tumor angiogenesis and interstitial hypertension. Cancer Res. 1996; 56: 4264-4266.
7. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 1955; 9: 539-549.
8. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic environment of human tumors: a review. Cancer Res. 1989; 49: 6449-6465.
9. 2 gradients in window chamber tumours: impact on tumour hypoxia. Br. J. Cancer 1999; 79: 1717-1722.
10. Secomb TW, Hsu R, Braun RD, Ross JR, Gross JF, Dewhirst MW. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv. Exp. Med. Biol. 1998; 454: 629-634.
11. Dewhirst DW. Concepts of oxygen transport at the microcirculatory level. Semin. Radiat. Oncol. 1998; 8: 143-150.
12. Chaplin DJ, Durand RE, Olive PL. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int. J. Radiat. Oncol. Biol. Phys. 1986; 12: 1279-1282.
13. Dewhirst MW, Kimura H, Rehmus SW, Braun RD, Papahadjopoulos D, Hong K, Secomb TW. Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer 1996; 27: S247-S251.
14. Trotter MJ, Olive PL, Chaplin DJ. Effect of vascular marker Hoechst 33342 on tumor perfusion and cardiovascular function in the mouse. Br. J. Cancer 1990; 62: 903-908.
15. Chaplin DJ, Hill SA. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumors. Br. J. Cancer 1990; 62: 903-908.
16. Hill SA, Pigott KH, Saunders MI, Powell ME, Arnold S, Obeid A, Ward G, Leahy M, Hoskin PJ, Chaplin DJ. Microregional blood flow in murine and human tumors assessed using laser-Doppler microprobes. Br. J. Cancer 1996; 27: S260-S263.
17. Braun RD, Lanzen JL, Dewhirst MW. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am. J. Physiol. 1999; 277: H551-H568.
18. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, Dewhirst MW. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 1996; 56: 5522-5528.
19. Intaglietta M, Myers RR, Gross JF, Reinhold HS. Dynamics of microvascular flow in implanted mouse mammary tumors. Bibl. Anat. 1977; 15: 273-276.
20. Patan S, Munn LL, Jain RK. Intususceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc. Res. 1996; 51: 260-272.
21. Kiani MF, Pries AR, Hsu LL, Sarelius IH, Cokelet GR. Fluctuations in microvascular blood flow parameters caused by hemodynamic mechanisms. Am. J. Physiol. 1994; 266: H1822-H1828.
22. Mollica F, Jain RK, Netti PA. A model for temporal heterogeneities of tumor blood flow. Microvasc. Res. 2003; 65: 56-60.
23. Rofstad EK. Micro-environment-induced cancer metastasis. Int. J. Radiat. Biol. 2000; 76: 589-605.
24. Young SD, Marshall RS, Hill RP. Hypoxia induced DNA over-replication and enhances metastatic potential of murine tumor cels. Proc. Natl Acad. Sci. USA 1998; 85: 9533-9537.
25. Rofstad EK, Danielsen T. Hypoxia induces metastasis of human melanoma cells: involvement of VEGF mediated angiogenesis. Br. J. Cancer 2002; 80: 1697-1707.
26. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 2001; 61: 8903-8908.
27. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996; 379: 88-91.
28. Hockel M, Schlenger K, Hockel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 1999; 59: 4525-4528.
29. Semenza GL. Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J. Clin. Invest. 2001; 108: 39-40.
30. Harris AL. Hypoxia: a key regulatory factor in tumor growth. Nat. Rev. Cancer 2002; 2: 38-47.
31. Semenza GL. The metabolism of tumors: 70 years later. Novartis Found. Sympos. 2001; 240: 251-260.
32. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic and molecular aspects. J. Natl Cancer Inst. 2001; 93: 266-276.
33. Hall EJ. Radiobiology for the Radiologist, 4th edn. Lippincott: Philadelphia, PA, 1994.
34. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 1953; 26: 638-648.
35. Hill RP. Cellular basis for radiotherapy. In The Basic Science of Oncology, 2nd edn, Tannock IF, Hill RP (eds). McGraw-Hill: New York, 1992; 259-275.
36. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Broder PJ. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1987; 14: 831-838.
37. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 1993; 26: 45-50.
38. Hockel M, Knoop C, Schlenger K, Baussman E, Knapstein P. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the cervix. Gynecol. Oncol. 1993; 51: 141-149.
39. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin. Radiat. Oncol. 1996; 6: 3-9.
40. Okunieff P, Hoeckelm M, Dunphy EP, Schlenger K, Knoop C, Vaupel P. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 1993; 26: 631-636.
41. Stone HB, Brown JM, Philips TL, Sutherland RM. Oxygen in human tumors: correlation between methods of measurement and response to therapy. Radiat. Res. 1993; 136: 422-434.
42. 2 measurements in one rodent and two human xenografts. Radiat. Res. 1994; 139: 1-8.
43. Swartz HM. The measurement of oxygen in vivo using EPR techniques. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 403-440.
44. Durand RE. The influence of microenvironmental factors during cancer therapy. In Vivo 1994; 8: 691-702.
45. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mammary tumor. Br. J. Cancer 1968; 22: 258-273.
46. Olive PL. Distribution, oxygenation and clonogenicity of macrophages in a murine tumor. Cancer Commun. 1989; 1: 93-100.
47. Teicher BA, Holden SA, Al-Achi A, Herman TS. Classification of anti-neoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaII murine fibrosarcoma. Cancer Res. 1990; 50: 3339-3344.
48. Sakata K, Kwok TT, Murphy BJ, Laderoute KR, Gordon GR, Sutherland RM. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br. J. Cancer 1991; 64: 809-814.
49. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin AR, Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 1996; 56: 1374-1381.
50. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C. Extracellular matrix proteins protect small cell lung cancer against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 1999; 5: 662-668.
51. Durand RE. Intermittent blood flow in solid tumors. An under-appreciated source of drug resistance. Cancer Metastasis Rev. 2001; 20: 57-61.
52. Durand RE. Clinical relevance of intermittent tumour blood flow. Acta Oncol. 2001; 40: 929-936.
53. 2-histography. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 953-961.
54. Dewhirst MW, Klitzman B, Braun RD, Brizel DM, Haroon ZA, Secomb TW. Review of methods to study oxygen transport at the microcirculatory level. Int. J. Cancer 2000; 90: 237-255.
55. Dewhirst MW, Secomb TW, Ong ET, Hsu R, Gross JF. Determination of local oxygen consumption rates in tumors. Cancer Res. 1994; 54: 3333-3336.
56. Dewhirst MW, Ong ET, Rosner GL, Rehmus SW, Shan S, Brau RD, Brizel DM, Secomb TW. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br. J. Cancer 1996; 27: S241-S246.
57. 2 in tumors in response to carbogen breathing. Int. J. Radiat. Oncol. Biol. Phys. 1998; 42: 855-859.
58. Ressel A, Weiss C, Feyerabend T. Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1119-1125.
59. Griffiths JR, Robinson SP. The OxyLite: a fiber optic oxygen sensor. Br. J. Radiol. 1999; 72: 627-630.
60. Seddon BM, Honess DJ, Vojnovic B, Tozer GM, Workman P. Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumor. Radiat. Res. 2001; 155: 837-846.
61. Braun RD, Lanzen JL, Snyder SA, Dewhirst MW. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrode in rodents. Am. J. Physiol. 2001; 280: H2533-H2544.
62. Bussink J, Kanders JH, Strik AM, vander Kogel AJ. Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescence based fiber-optic probes. Radiother Oncol. 2000; 57: 21-30.
63. Demeure RJ, Jordan BF, Yang QX, Beghein N, Smith MB, Gregoire V, Gallez B. Removal of local field gradient artefacts in BOLD contrast imaging of head and neck tumors. Phys. Med. Biol. 2002; 47: 1819-1825.
64. Jarm T, Sersa G, Miklavcic D. Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor. Technol. Health Care 2002; 10: 363-380.
65. 2) inside tumors? Magn. Reson. Med. 2002; 48: 980-986.
66. Jordan BF, Gregoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara JA, Vanhulle VP, Delzenne N, Gallez B. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res. 2002; 62: 3555-3561.
67. Jordan BF, Beghein N, Aubry M, Gregoire V, Gallez B. Potentiation of radiation-induced delay by isosorbide dinitrate in FSAII murine tumors. Int. J. Cancer 2003; 103: 138-141.
68. Jordan BF, Sonveaux P, Feron O, Gregoire V, Beghein N, Gallez B. Nitric oxide mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55: 1066-1073.
69. Brurberg KG, Graff BA, Rofstad EK. Temporal heterogeneity in oxygen tension in human melanoma xenografts. Br. J. Cancer 2003; 21: 350-356.
70. Wilson DF, Vinogradov SA, Dugan BW, Biruski D, Waldron L, Evans SA. Measurement of tumor oxygenation using new frequency domain phosphoremeters. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2002; 132: 153-159.
71. Wilson DF. Oxygen dependent quenching of phosphorescence: a perspective. Adv. Exp. Med. Biol. 1992; 317: 195-201.
72. Vinogradov SA, Lo LW, Jenkins WT, Evans SM, Koch C, Wilson DF. Non invasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors. Biophys. J. 1996; 70: 1609-1617.
73. Hull EL, Conover DL, Foster TH. Carbogen-induced changes in rat mammary tumor oxygenation reported by near-infrared spectroscopy. Br. J. Cancer 1999; 79: 1709-1716.
74. Liu HL, Song YL, Worden KL, Jiang X, Constantinescu A, Mason RP. Non invasive investigation of blood oxygenation dynamics of tumors by near-infrared spectroscopy. Applied optics 2000; 39: 5231-5243.
75. Wray S, Cope M, Delpy DT, Wyatt JS, Reynolds OR. Characterisation of the near-infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation. Biochim. Biophys. Acta 1988; 933: 184-192.
76. Varghese AJ, Gulyas S, Mohindra JK. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res. 1976; 36: 3761-3765.
77. Raleigh JA, Franko AJ, Koch CJ, Born JL. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label. Br. J. Cancer 1985; 51: 229-235.
78. Raleigh JA, Koch CJ. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmac. 1990; 40: 2457-2464.
79. Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br. J. Cancer 1981; 43: 546-550.
80. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer 1995; 61: 567-573.
81. Raleigh JA, Chou SC, Arteel GE, Horsman MR. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 1999; 151: 580-589.
82. Mahy P, De Bast M, Gallez B, Gueulette J, Koch CJ, Scalliet P, Grégoire V. In vivo co-localization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. Radiother Oncol. 2003; 67: 53-61.
83. 18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. Bioorg. Med. Chem. 2001; 9: 665-675.
84. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother. Oncol. 1998; 46: 229-237.
85. Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 1997; 37: 897-905.
86. Bussink J, Kaanders JH, Rijken PF, Peters JP, Hodgkiss RJ, Marres HA, van der Kogel AJ. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiother Oncol. 1999; 50: 173-184.
87. Gillies RJ, Raghunand N, Karczmar G, Bhujwalla ZM. MRI of the tumor microenvironment. J. Magn. Reson. Imag. 2002; 16: 430-450.
88. Grucker D. Oxymetry by magnetic resonance: applications to animal biology and medicine. Prog. Nucl. Magn. Reson. Spectrosc. 2000; 36: 241-270.
89. 19F magnetic resonance imaging. Invest. Radiol. 1988; 23: 361-364.
90. 19F NMR imaging of liver, tumor, and abscess in rats. Preliminary results. Invest. Radiol. 1985; 20: 141-145.
91. 19F and dissolved oxygen. Adv. Exp. Med. Biol. 1984; 180: 835-845.
92. 19F NMR indicator of tumor oxygenation. NMR Biomed. 1996; 9: 125-134.
93. McIntyre DJO, McCoy CL, Griffiths JR. Tumour oxygenation measurements by F-19 magnetic resonance imaging of perfluorocarbons. Curr. Sci. 1999; 76: 753-762.
94. Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP, Mason RP. Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 1097-1108.
95. Mason RP, Ran S, Thorpe PE. Quantitative assessment of tumor oxygen dynamics: molecular imaging for prognostic radiology. J. Cell. Biochem. 2002; 39(suppl.): 45-53.
96. Zhao D, Constantinescu A, Hahn EW, Mason RP. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 744-756.
97. Aboagye EO, Kelson AB, Tracy M, Workman P. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography. Anticancer Drug Res. 1998; 13: 703-730.
98. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA 1990; 87: 9868-9872.
99. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 1990; 14: 68-78.
100. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed. 2001; 14: 497-506.
101. Al-Hallaq HA, Fan X, Zamora M, River JN, Moulder JE, Karczmar GS. Spectrally inhomogeneous contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed. 2002; 15: 28-36.
102. Kaanders JH, Bussink J, van der Kogel AJ. ARCON: a novel biology-based approach in radiotherapy. Lancet Oncol. 2002; 3: 728-737.
103. Karczmar GS, Kuperman VY, River JN, Lewis MZ, Lipton MJ. Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest Radiol. 1994; 29: S161-S163.
104. Robinson SP, Howe FA, Griffiths JR. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33: 855-859.
105. Robinson SP, Rodrigues LM, Ojugo AS, McSheehy PM, Howe FA, Griffiths JR. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br. J. Cancer 1997; 75: 1000-1006.
106. Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell ME, Thoumine M, Caine LA, Baddeley H. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39: 697-701.
107. Jordan BF, Misson P, Demeure R, Baudelet C, Beghein N, Gallez B. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 565-570.
108. Landuyt W, Hermans R, Bosmans H, Sunaert S, Beatse E, Farina D, Meijerink M, Zhang H, Van Den Bogaert W, Lambin P, Marchal G. BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. Eur. J. Radiol. 2001; 11: 2332-2340.
109. Taylor NJ, Baddeley H, Goodchild KA, Powell ME, Thoumine M, Culver LA, Stirling JJ, Saunders MI, Hoskin PJ, Phillips H, Padhani AR, Griffiths JR. BOLD MRI of human tumor oxygenation during carbogen breathing. J. Magn. Reson. Imag. 2001; 14: 156-163.
110. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1185-1191.
111. Robinson SP, Collingridge DR, Howe FA, Rodrigues LM, Chaplin DJ, Griffiths JR. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed. 1999; 12: 98-106.
112. Howe FA, Robinson SP, Rodrigues LM, Griffiths JR. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn. Reson. Imag. 1999; 17: 1307-1318.
113. Lebon V, Carlier PG, Brillault-Salvat C, Leroy-Willig A. Simultaneous measurement of perfusion and oxygenation changes using a multiple gradient-echo sequence: application to human muscle study. Magn. Reson. Imag. 1998; 16: 721-729.
114. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int. J. Rodiat. Oncol. Biol. Phys. 1998; 41: 151-159.
115. Baudelet C, Gallez B. Cluster analysis of BOLD fMRI time series in tumors to study the heterogeneity of hemodynamic response to treatment. Magn. Reson. Med. 2003; 49: 985-990.
116. Baudelet C, Ansiaux R, Jordan BF, Havaux X, Macq B, Gallez B. Physiological noise in murine solid tumors using T2* weighted gradient-echo imaging: a marker of tumor acute hypoxia? Phys. Med. Biol. 2004; 49: 3389-3411.
117. Baudelet C, Anciaux R, Macq B, Gallez B. Non invasive mapping of spontaneous blood flow/oxygen fluctuations in tumors using functional Magnetic Resonance Imaging and their modifications by pharmacological treatments. Proc. Int. Soc. Mag. Reson. Med. 2003; 11: 1225.
118. Mäder K, Stösser R, Borchert HH. Detection of free radicals in living mice after inhalation of DTBN by X-Band ESR. Free Rad. Biol. Med. 1993; 14: 339-342.
119. Gallez B, Bacic G, Goda F, Jiang J, O'Hara JA, Dunn JF, Swartz HM. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies. Magn. Reson. Med. 1996; 35: 97-106.
120. Nilges MJ, Walczak T, Swartz HM. 1 GHz in vivo ESR spectrometer operating with a surface probe. Phys. Med. 1989; 5: 195-201.
121. Berliner LJ, Koscielniak J. Low-frequency EPR spectrometers: L band. In EPR Imaging and in Vivo EPR, Eaton GR, Eaton SS, Ohno K (eds). CRC Press: Boca Raton, FL, 1991; 65-77.
122. Halpern HJ, Bowman MK. Low frequency EPR spectrometers: MHz range. In EPR Imaging and in Vivo EPR, Eaton GR, Eaton SS, Ohno K (eds). CRC Press: Boca Raton, FL, 1991; 45-63.
123. Subramanian S, Mitchell JB, Krishna MC. Principles of in vivo EPR. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 23-40.
124. Krishna MC, Subramanian S, Kuppusamy P, Mitchell JB. Magnetic resonance imaging for in vivo assessment of tissue oxygenation concentration. Semin. Radiat. Oncol. 2001; 11: 58-69.
125. Koscielniak J. CW EPR signal detection bridges. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 61-72.
126. Lurie DJ. Free radical imaging. Br. J. Radiol. 2001; 74: 782-784.
127. Subramanian S, Murugesan R, Devasahayam N, Cook JA, Afeworki M, Pohida T, Tschudin RG, Mitchell JB, Krishna MC. High speed data acqusition system and receiver configurations for time-domain radiofrequency electron paramagnetic resonance spectroscopy and imaging. J. Magn. Reson. 1999; 137: 379-388.
128. Subramanian S, Yamada KI, Irie A, Murugesan R, Cook JA, Devasahayam N, Van Dam GM, Mitchell JB, Krishna MC. Non invasive in Vivo oximetric imaging by radiofrequency FT EPR. Magn. Reson. Med. 2002; 47: 1001-1008.
129. Subramanian S, Mitchell JB, Krishna MC. Time-domain radio frequency EPR imaging. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 153-197.
130. Gallez B, Mäder K, Swartz HM. Non invasive measurement of the pH inside the gut by using pH-sensitive nitroxides. An in vivo EPR study. Magn. Reson. Med. 1996; 36: 694-697.
131. Mäder K, Gallez B, Liu KJ, Swartz HM. Non invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron parmagnetic resonance spectroscopy. Biomaterials 1996; 17: 457-461.
132. Mäder K, Bacic G, Domb A, Elmalak O, Langer R, Swartz HM. Non invasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imging. J. Pharm. Sci. 1997; 86: 126-134.
133. Halpern HJ, Chandramouli GV, Barth ED, Yu C, Peric M, Grdina DJ, Teicher BA. Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res. 1999; 59: 5836-5841.
134. Hyde JS, Subczynski WK. Spin-label oximetry. In Spin Labeling: Theory and Applications: Biological Magnetic Resonance, Vol. 8, Berliner LJ, Reuben J (eds). Plenum Press: New York, 1989; 399-425.
135. Swartz HM, Glockner JF. Measurement of oxygen by EPRI and EPRS. In EPR Imaging and in Vivo EPR, Eaton GR, Eaton SS, Ohno K (eds). CRC Press: Boca Raton, FL, 1991; 261-290.
136. Turek P, Moussavi M, Andre JJ. Magnetic properties of the lithium phthalocyanine PI-radical. Role of dioxygen. Europhys. Lett. 1989; 8: 275-280.
137. Bensebaa F, Andre JJ. Effect of oxygen on phthalocyanine radicals - 1: ESR study of lithium phthalocyanine spin species at different oxygen concentrations. J. Phys. Chem. 1992; 96: 5739-5745.
138. Bensebaa F, Petit P, Andre JJ. The effect of oxygen on phthalocyanine radicals - 2: comparative study of 2 lithium phthalocyanine powder derivatives by continuous and pulsed ESR. Synth. Metals 1992; 52: 57-69.
139. Lewis IC, Singer LS. Electron spin resonance and the mechanism of carbonization. Chem. Phys. Carbon 1981; 17: 1-88.
140. Clarkson RB, Odintsov BM, Ceroke PJ, Ardenkjaer-Larsen JH, Fruiamu M, Belford RL. Electron paramagnetic resonance and dynamic nuclear polarization of char suspensions: surface science and oximetry. Phys. Med. Biol. 1998; 43: 1907-1920.
141. Atsarkin VA, Demidov VV, Vasneva GA, Dzheparov FS, Ceroke PJ, Odintsov BM, Clarkson RB. Mechanisms of oxygen response in carbon-based sensors. J. Magn. Reson. 2001; 149: 85-89.
142. Swartz HM, Clarkson RB. The measurement of oxygen in vivo using EPR techniques. Phys. Med. Biol. 1998; 43: 1957-1975.
143. Kocherginsky N, Swartz HM. Terminology, classification and distribution of the nitroxides in cells. In Nitroxide Spin Labels: Reactions in Biology and Chemistry, Kocherginsky N, Swartz HM (eds). CRC Press: Boca Raton, FL, 1995; 15-26.
144. Gallez B, Debuyst R, Demeure R, Dejehet F, Grandin C, Van Beers B, Taper H, Pringot J, Dumont P. Evaluation of a nitroxyl fatty acid as liver contrast agent for magnetic resonance imaging. Magn. Reson. Med. 1993; 30: 592-599.
145. Gallez B, Lacour V, Demeure R, Debuyst R, Dejehet F, De Keyser JL, Dumont P. Spin labelled arabinogalactan as MRI contrast agent. Magn. Reson. Imag. 1994; 12: 61-69.
146. Halpern HJ, Yu C, Peric M, Barth E, Grdina DJ, Teicher BA. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc. Natl Acad. Sci. USA 1994; 91: 13047-13051.
147. Liu KJ, Grinstaff MW, Jiang J, Suslick KS, Swartz HM, Wang W. In vivo measurement of oxygen concentration using sonochemically synthsized microspheres. Biophys. J. 1994; 67: 896-901.
148. Grucker D, Guiberteau T, Eclancher B, Chambron J, Chiarelli R, Rassat A, Subra G, Gallez B. Dynamic nuclear polarization with nitroxides dissolved in biological fluids. J. Magn. Reson. B 1995; 106: 101-109.
149. Guiberteau T, Grucker D. Dynamic nuclear polarization imaging in very low magnetic fields as a non invasive technique for oximetry. J. Magn. Reson. 1997; 124: 263-266.
150. Chen K, Glockner JF, Morse PD, Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 1989; 28: 2496-2501.
151. Pals MA, Swartz HM. Oxygen dependent metabolism of potential magnetic resonance contrast agents. Invest. Radiol. 1987; 22: 497-501.
152. Swartz HM. Use of nitroxides to measure redox metabolis in cells and tissues. J. Chem. Soc., Faraday Trans. 1 1987; 83: 191.
153. Swartz HM, Chen K, Pals M, Sentjurc M, Morse PD. Hypoxia-sensitive NMR contrast agents. Magn. Reson. Med. 1986; 3: 169.
154. Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, Mitchell JB. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res. 2002; 62: 307-312.
155. Ilangovan G, Li H, Zweier JL, Krishna MC, Mitchell JB, Kuppusamy P. In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Magn. Reson. Med. 2002; 48: 723-730.
156. Ardenkjaer-Larsen JH, Laursen I, Leunbach I, Ehnholm G, Wistrand LG, Peterson JS, Golman K. EPR and DNP properties of certain novel single electron contrast agents intended for oximetric image. J. Magn. Reson. 1998; 133: 1-12.
157. Panagiotelis I, Nicholson I, Hutchison JMS. Electron spin relaxation time measurements using radiofrequency longitudinally detected ESR and application in oximetry. J. Magn. Reson. 2001; 149: 74-84.
158. Yong L, Harbridge J, Quine RW, Rinard GA, Eaton SS, Eaton GR, Mailer C, Barth E, Halpern HJ. Electron spin relaxation of triarylmethyl radicals in fluid solution. J. Magn. Reson, 2001; 152: 156-161.
159. Matsumoto KI, Chandrika B, Lohman JAB, Mitchell JB, Krishna MC, Subramanian S. Application of continuous-wave EPR spectral-spatial image reconstruction techniques for in vivo EPR oxymetry: comparison of projection reconstruction and constant-time modalities. Magn. Reson. Med. 2003; 50: 865-874.
160. Elas M, Williams BB, Parasca A, Mailer C, Pelizzari CA, Lewis MA, River JN, Karczmar GS, Barth ED, Halpern HJ. Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn. Reson. Med. 2003; 49: 682-691.
161. Golman K, Petersson JS, Ardenkjaer-Larsen JH, Leunbach I, Wistrand LG, Ehnholm G, Liu K. Dynamic in vivo oximetry using Overhauser enhanced MR imaging. J. Magn. Reson. Imaging 2000; 12: 929-938.
162. Li H, Deng Y, He G, Kuppusamy P, Lurie DJ, Zweier JL. Proton electron double resonance imaging of the in vivo distribution and clearance of a triaryl methyl radical in mice. Magn. Reson. Med. 2002; 48: 530-534.
163. Krishna MC, English S, Yamada K, Yoo J, Murugesan R, Devasahayam N, Cook JA, Golman K, Ardenkjaer-Laersen JH, Subramanian S, Mitchell JB. Overhauser enhanced magnetic resonance imaging for tumor oximetry: co-registration of tumor anatomy and tissue oxygen concentration. Proc. Natl Acad. Sci. USA 2002; 99: 2216-2221.
164. Reddy TJ, Iwama T, Halpern HJ, Rawal VH. General synthesis of persistent trityl radicals for EPR imaging of biological systems. J. Org. Chem. 2002; 67: 4635-4639.
165. Swartz HM. Measuring real levels of oxygen in vivo: opportunities and challenges. Biochem. Soc. Trans. 2002; 30: 248-252.
166. Dunn JF, Swartz HM. In vivo electron paramagnetic resonance
167. Liu KJ, Gast P, Moussavi M, Norby SW, Vahidi N, Walczak T, Wu M, Swartz HM. Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc. Natl Acad. Sci. USA 1993; 90: 5438-5442.
168. Hou H, Grinberg OY, Taie S, Leichtweis S, Miyake M, Grinberg S, Xie H, Csete M, Swartz HM. Electron paramagnetic resonance assessment of brain tissue oxygen tension in anesthetized rats. Anesth. Analg. 2003; 96: 1467-1472.
169. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, Lei H, Meyerand ME, Grinberg OY, Hou H, Hoopes PJ, Demidenko E, Swartz HM. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J. Magn. Reson. Imag. 2002; 16: 511-521.
170. Lei H, Grinberg O, Nwaigwe CI, Hou HG, Williams H, Swartz HM, Dunn JF. The effects of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res. 2001; 913: 174-179.
171. Ilangovan G, Manivannan A, Li H, Yanagi H, Zweier JL, Kuppusamy P. A naphthalocyanine-based EPR probe for localized measurements of tissue oxygenation. Free Rad. Biol. Med. 2002; 32: 139-147.
172. Vahidi N, Clarkson RB, Liu KJ, Norby SW, Swartz HM. In vivo and in vitro EPR oximetry with fusinite: a new coal-derived, particulate EPR probe. Magn. Reson. Med. 1994; 31: 139-146.
173. Norby SW, Swartz HM, Clarkson RB. Electron and light microscopy studies on particulate EPR spin probes lithium phthalocyanine, fusinite and synthetic chars. J. Microsc. 1998; 192: 172-185.
174. James PE, Grinberg OY, Goda F, Panz T, O'Hara JA, Swartz HM. Gloxy: an oxygen-sensitive coal for accurate measurement of low oxygen tensions in biological systems. Magn. Reson. Med. 1997; 38: 48-58.
175. Jordan BF, Baudelet C, Gallez B. Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals. MAGMA 1998; 7: 121-129.
176. Gallez B, Jordan BF, Baudelet C, Misson PD. Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry. Magn. Reson. Med. 1999; 42: 627-630.
177. Boyer SJ, Clarkson RB. Electron paramagnetic reonance studies of an active carbon: the influence of preparation procedure on the oxygen response of the linewidth. Colloid Surface A 1994; 82: 217-224.
178. Clarkson RB, Ceroke P, Norby SW, Odintsov BM. Stable particulate paramagnetic materials as oxygen sensors in EPR oximetry. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 233-257.
179. He J, Beghein N, Clarkson RB, Swartz HM, Gallez B. Microencapsulation of carbon particles used as oxygen sensors in EPR oximetry to stabilize their responsiveness to oxygen in vitro and in vivo. Phys. Med. Biol. 2001; 46: 3323-3329.
180. He J, Beghein N, Ceroke P, Clarkson RB, Swartz HM, Gallez B. Development of biocompatible oxygen-permeable films holding paramagnetic carbon particles: evaluation of their performance and stability in EPR oximetry. Magn. Reson. Med. 2001; 46: 610-614.
181. Swartz HM, Liu KJ, Goda F, Walczak T. India ink: a potential clinically applicable EPR oximetry probe. Magn. Reson. Med. 1994; 31: 229-232.
182. Goda F, Liu KJ, Walczak T, O'Hara JA, Jiang J, Swartz HM. In vivo oximetry using EPR and India ink. Magn. Reson. Med. 1995; 33: 237-245.
183. Lan M, Beghein N, Charlier N, Gallez B. Carbon blacks as EPR sensors for localized measurements of tissue oxygenation. Magn. Reson. Med. 2004; 51: 1272-1278.
184. Smirnov AI, Norby SW, Clarkson RB, Walczak T, Swartz HM. Simultaneous multi-site EPR spectroscopy in vivo. Magn. Reson. Med. 1993; 30: 213-220.
185. Berliner LJ, Fujii H. Magnetic resonance imaging of biological specimens by electron paramagnetic resonance of nitroxide spin labels. Science 1985; 227: 517-519.
186. Berliner LJ, Fujii H, Wan XM, Lukiewicz SJ. Feasibility study of imaging a living murine tumor by electron paramagnetic resonance. Magn. Reson. Med. 1987; 4: 380-384.
187. Ohno K. ESR imaging: a deconvolution method for hyperfine patterns. J. Magn. Reson. 1982; 50: 145-150.
188. Woods RK, Bacic GG, Lauterbur PC, Swartz HM. Three-dimensional electron spin resonance imaging. J. Magn. Reson. 1989; 84: 247-254.
189. Colacicchi S, Ferrari M, Sotgiu A. In vivo electron paramagnetic resonance spectroscopy/imaging: first experiences, problems, and perspectives. Int. J. Biochem. 1992; 24: 205-214.
190. Kuppusamy P, Chzhan M, Zweier JL. Principles of imaging. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 99-152.
191. Woods RK, Dobrucki JW, Glockner JD, Morse PD, Swartz HM. Spectral-spatial imaging as a method for non invasive biological oximetry. J. Magn. Reson. 1989; 85: 50-59.
192. Woods RK, Hyslop WB, Swartz HM. Mapping oxygen concentrations with 4D electron spin resonance spectral-spatial imaging. Phys. Med. 1989; 2-4: 121-137.
193. Kuppusamy P, Chzhan M, Vij K, Shtynbuk M, Lefer DJ, Gianella E, Zweier JL. Three-dimensional spectral-spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolism and oxygenation. Proc. Natl Acad. Sci. USA 1994; 91: 3388-3392.
194. He G, Shankar RA, Chzhan M, Samouilov A, Kuppusamy P, Zweier JL. Noninvasive measurement of anatomic structure and intrluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc. Natl Acad. Sci. USA 1999; 96: 4586-4591.
195. Velan SS, Spencer RGS, Zweier JL, Kuppusamy P. Electron paramagnetic resonance oxygen mapping (EPROM): direct visualization of oxygen concentration in tissue. Magn. Reson. Med. 2000; 43: 804-809.
196. Ellis SJ, Velayutham M, Velan SS, Petersen EF, Zweier JL, Kuppusamy P, Spencer RGS. EPR oxygen mapping (EPROM) of engineered cartilage grown in a hollow-fiber bioreactor. Magn. Reson. Med. 2001; 46: 819-826.
197. Kuppusamy P, Shankar RA, Zweier JL. In vivo measurement of arterial and venous oxygenation in the rat using 3D spectral-spatial electron paramagnetic resonance imaging. Phys. Med. Biol. 1998; 43: 1837-1844.
198. He G, Samouilov A, Kuppusamy P, Zweier JL. In vivo imaging of free radicals: applications from mouse to man. Moll. Cell. Biochem. 2002; 234-235: 359-367.
199. Lurie DJ, Bussell DM, Bell LH, Mallard JR. Proton electron double resonance imaging of free radicals in large aqueous samples. J. Magn. Reson. 1988; 76: 366-370.
200. Lurie DJ, Foster MA, Yeung D, Hutchison JMS. Design, construction and use of a large-sample field-cycled PEDRI imager. Phys. Med. Biol. 1998; 43: 1877-1886.
201. Foster MA, Seimenis I, Lurie DJ. The application of PEDRI to the study of free radicals in vivo. Phys. Med. Biol. 1998; 43: 1893-1897.
202. Grucker D. In vivo detection of injected free radicals by Over-hauser effect imaging. Magn. Reson. Med. 1990; 14: 140-147.
203. Lurie DJ. Proton-electron double-resonance imaging (PEDRI). In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 547-578.
204. Lurie DJ, Hutchison JMS, Bell LH, Nicholson I, Bussel DM, Mallard JR. Field-cycled proton-electron double-resonance imaging of free radicals in large aqueous samples. J. Magn. Reson. 1989; 84: 431-437.
205. Grucker D, Chambron J. Oxygen imaging in perfused hearts by dynamic nuclear polarization. Magn. Reson. Imag. 1993; 11: 691-696.
206. Grucker D, Guiberteau T, Eclancher B. Oximetry by dynamic nuclear polarization. Magn. Reson. Med. 1995; 34: 219-226.
207. Friedman BJ, Grinberg OY, Isaacs K, Walczak T, Swartz HM. Myocardial oxygen tension and relative capillary density in isolated perfused rat hearts. J. Mol. Cell. Cardiol. 1995; 27: 2551-2558.
208. Friedman BJ, Grinberg OY, Isaacs K, Ruuge EK, Swartz HM. Effect of repetitive ischemia on local myocardial oxygen tension in isolated perfused and hypoperfused rat hearts. Magn. Reson. Med. 1996; 35: 214-220.
209. 2 measured by EPR. Adv. Exp. Med. Biol. 1997; 428: 261-268.
210. Zweier JL, Thompson-Gorman S, Kuppusamy P. Measurement of oxygen concentration in the intact beating heart using electron paramagnetic resonance spectroscopy: a technique for measuring oxygen concentration in situ. J. Bioenerg. Biomembr. 1991; 23: 855-871.
211. Zweier JL, Samouilov A, Kuppusamy P. Cardiac applications of in vivo EPR spectroscopy and imaging. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 441-468.
212. 2 in the liver in vivo in mice. Magn. Reson. Med. 1995; 34: 888-892.
213. 2 in liver using EPR oximetry. J. Appl. Physiol. 1996; 80: 552-558.
214. Gallez B, Debuyst R, Dejehet F, Liu KJ, Walczak T, Goda F, Demeure R, Taper H, Swartz HM. Small particles of fusinite and carbohydrate chars coated with aqueous soluble polymers: preparation and applications for EPR oximetry. Magn. Reson. Med. 1998; 40: 152-159.
215. James PE, Madhani M, Roebuck W, Jackson SK, Swartz HM. Endotoxin-induced liver hypoxia: defective oxygen delivery versus oxygen consumption. Nitric Oxide 2002; 6: 18-28.
216. Madhani M, Barchowsky A, Klei L, Ross CR, Jackson SK, Swartz HM, James PE. Antibacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim. Biophys. Acta 2002; 1588: 232-240.
217. James PE, Miyake M, Swartz HM. Simultaneous measurement of NO and PO(2) from tissue by in vivo EPR. Nitric Oxide 1999; 3: 292-301.
218. 2 measured by in vivo electron paramagnetic resonance oximetry and magnetic resonance imaging. Free Rad. Biol. Med. 1996; 21: 25-34.
219. Krzic M, Sentjurc M, Kristl J. Improved skin oxygenation after benzoyl nicotinate application in different carriers as measured by EPR oximetry in vivo. J. Control. Release 2001; 70: 203-211.
220. He G, Kutala VK, Kuppusamy P, Zweier JL. In vivo measurement and mapping of skin redox stress induced by ultraviolet light exposure. Free Rad. Biol. Med. 2004; 36: 665-672.
221. Bacic G, Liu KJ, O'Hara JA, Harris RD, Szybinski K, Goda F, Swartz HM. Oxygen tension in a murine tumor: a combined EPR and MRI study. Magn. Reson. Med. 1993; 30: 568-572.
222. Pandian RP, Parinandi NL, Ilangovan G, Zweier JL, Kuppusamy P. Novel particulate spin probe for targeted determination of oxygen in cells and tissues. Free Rad. Biol. Med. 2003; 35: 1138-1148.
223. 2 in tissue in vivo by EPR oximetry and microelectrodes. Adv. Exp. Med. Biol. 1997; 411: 543-549.
224. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, Lei H, Meyerand ME, Grinberg OY, Hou H, Hoopes PJ, Demidenko, E, Swartz HM. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J. Magn. Reson. Imag. 2002; 16: 511-521.
225. Song CW. Modification of blood flow. In Blood Perfusion and Microenvironment of Human Tumors, Molls M, Vaupel P (eds). Springer: Berlin, 1998; 193-207.
226. Wood PJ, Stratford IJ, Adams GE, Szabo C, Thiemermann C, Vane JR. Modification of the energy metabolism and radiation response of murine tumor by changes in nitric oxide availability. Biochem. Biophys. Res. Commun. 1993; 192: 505-510.
227. Muruganandham M, Kasiviswanathan A, Jagannathan NR, Raghunathan P, Jain PC, Jain V. Diltiazem enhances tumor blood flow: MRI study in a murine tumor. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 416-421.
228. Jordan BF, Sonveaux P, Feron O, Grégoire V, Beghein N, Dessy C, and Gallez B. Nitric oxide as radiosensitizer: evidence for an intrinsic role additive to its effect on oxygen delivery and consumption. Int. J. Cancer 2004; 109: 768-773.
229. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Cemazar M, Auersperg M, Swartz HM. Reduced tumor oxygenation by treatment with vinbastine. Cancer Res. 2001; 61: 4266-4271.
230. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz HM, Cemazar M. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br. J. Cancer 2002; 87: 1047-1054.
231. Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G, Swartz HM. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation. Cancer Res. 1995; 55: 2249-2252.
232. 2 in a murine tumor after irradiation: an in vivo electron paramagnetic resonance oximetry study. Radiat. Res. 1995; 144: 222-229.
233. Goda F, Bacic G, O'Hara JA, Gallez B, Swartz HM, Dunn JF. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res. 1996; 56: 3344-3349.
234. 2 measurements by electron paramagnetic resonance oximetry. Radiat. Res. 1998; 150: 549-556.
235. Sonveaux P, Dessy C, Brouet A, Jordan BF, Gregoire V, Gallez B, Balligand JL, Feron O. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery. FASEB J. 2002; 16: 1979-1981.
236. Pogue BW, O'Hara JA, Demidenko E, Wilmot CM, Goodwin IA, Chen B, Swartz HM, Hasan T. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res. 2003; 63: 1025-1033.
237. Pogue BW, O'Hara JA, Goodwin IA, Wilmot CJ, Fournier GP, Akay AR, Swartz H. Tumor PO(2) changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp. Biochem. Physiol. A 2002; 132: 177-184.
238. 2 measured by EPR oximetry in human tumor xenografts. Radiat. Res. 2001; 155: 466-473.
239. Gordon DG, Brasch RC, Ogan MD, Deen D. Pyrroxamide, a nonionic nitroxyl spin label contrast agent for magnetic resonance imaging: mutagenesis and cell survival. Invest Radiol. 1988; 23: 616-620.
240. Gallez B, De Meester C, Debuyst R, Dejehet F, Dumont P. Mutagenicity of nitroxyl compounds: structure-activity relationships. Toxicol. Lett. 1992; 63: 35-45.
241. Sosnovsky G. A critical evaluation of the present status of toxicity of aminoxyl radicals. J. Pharm. Sci. 1992; 81: 496-499.
242. Fuchs J, Groth N, Herrling T. Cutaneous tolerance to nitroxide free radicals in human skin. Free Radic. Biol. Med. 1998; 24: 643-648.
243. Krishna MC, DeGraff W, Hankovszky OH, Sar CP, Kalai T, Jeko J, Russo A, Mitchell JB, Hideg K. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J. Med. Chem. 1998; 41: 3477-3492.
244. 2 in vivo using low frequency EPR spectroscopy: how to confer biocompatibility to the oxygen sensors. Free Rad. Biol. Med. 2000; 29: 1078-1084.
245. Gallez B, Jordan B, Baudelet C. Microencapsulation of paramagnetic particles by pyrroxylin in order to preserve their responsiveness to oxygen when used as sensors for in vivo EPR oximetry. Magn. Reson. Med. 1999; 42: 193-196.
246. Gallez B, Debuyst R, Liu KJ, Demeure R, Dejehet F, Swartz HM. Development of biocompatible implants of fusinite for in vivo EPR oximetry. MAGMA 1996; 4: 71-75.
247. Swartz HM. Potential medical (clinical) applications of EPR: overview and perspectives. In in Vivo EPR (ESR): Theory and Applications: Biological Magnetic Resonance, Vol. 18, Berliner LJ (ed.). Kluwer Academic/Plenum: New York, 2003; 599-621.
248. Lurie DJ, Foster MA, Yeung D, Hutchison JMS. Design, construction and use of a large-sample field-cycled PEDRI imager. Phys. Med. Biol. 1998; 43: 1877-1886.
249. Lurie DJ, Li H, Petryakov S, Zweier JL. Development of a PEDRI free-radical imager using a 0.38 T clinical MRI system. Magn. Reson. Med. 2002; 47: 181-186.